Literature DB >> 15770055

Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.

Selim A Aydemir1, Isak Ozel Tekin, Gamze Numanoglu, Ali Borazan, Yucel Ustundag.   

Abstract

INTRODUCTION: Helicobacter pylori is one of the main causes of gastroduodenal diseases, such as chronic gastritis and peptic ulcer. It has been shown that eosinophils increase in the stomach in H. pylori infection. Eosinophilic cationic protein (ECP) is a cytotoxic molecule secreted by the activated eosinophils. However, there are no sufficient data about the role of ECP in H. pylori infection and its effect on ulcer development. In this study we investigated the gastric eosinophilic infiltration, gastric juice and serum ECP levels in patients with chronic gastritis and gastric ulcer associated with H. pylori.
MATERIALS AND METHODS: Forty-four H. pylori-positive and 20 H. pylori-negative patients who underwent upper gastrointestinal system endoscopy after admitting with dyspeptic complaints were enrolled in the study. Twenty-one of the H. pylori-positive patients had gastric ulcer while 23 patients had none. During endoscopy, multiple gastric biopsies and juices were taken. In gastric biopsies, H. pylori and eosinophilic infiltration were assessed. Additionally, gastric juice and serum ECP levels were measured.
RESULTS: Eosinophil infiltration, gastric juice ECP levels, and gastric juice/serum ECP ratios in the H. pylori-positive group were greater than in the H. pylori-negative group (p < 0.01). There was no statistically significant difference regarding serum ECP levels between the two groups (p > 0.05). When H. pylori-positive patients were compared with regard to gastric ulcer presence, however, there was no significant difference in gastric eosinophil infiltration, gastric juice ECP levels, serum ECP levels, and gastric juice/serum ECP ratios (p > 0.05).
CONCLUSION: The results of this study suggest that eosinophils and eosinophil-released ECP may contribute to inflammatory changes seen in chronic gastritis, whereas there is no proof that they play a role in ulcer development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15770055      PMCID: PMC1781585          DOI: 10.1155/S0962935104000559

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  34 in total

Review 1.  Pharmacology of the eosinophil.

Authors:  M A Giembycz; M A Lindsay
Journal:  Pharmacol Rev       Date:  1999-06       Impact factor: 25.468

2.  Secretion and tissue content of eosinophil cationic protein in Crohn's disease.

Authors:  S Winterkamp; M Raithel; E G Hahn
Journal:  J Clin Gastroenterol       Date:  2000-03       Impact factor: 3.062

3.  Helicobacter pylori gastritis in children and adults: comparative histopathologic study.

Authors:  A E Whitney; J Guarner; L Hutwagner; B D Gold
Journal:  Ann Diagn Pathol       Date:  2000-10       Impact factor: 2.090

4.  Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria.

Authors:  V Ojetti; A Armuzzi; A De Luca; E Nucera; F Franceschi; M Candelli; G F Zannoni; S Danese; S Di Caro; M Vastola; D Schiavino; G Gasbarrini; G Patriarca; P Pola; A Gasbarrini
Journal:  Int Arch Allergy Immunol       Date:  2001-05       Impact factor: 2.749

5.  Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.

Authors:  O Saitoh; K Kojima; K Sugi; R Matsuse; K Uchida; K Tabata; K Nakagawa; M Kayazawa; I Hirata; K Katsu
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

Review 6.  Recent developments in the epidemiology of Helicobacter pylori.

Authors:  J E Everhart
Journal:  Gastroenterol Clin North Am       Date:  2000-09       Impact factor: 3.806

7.  Acute presentation of Campylobacter pylori gastritis.

Authors:  D J Frommer; J Carrick; A Lee; S L Hazell
Journal:  Am J Gastroenterol       Date:  1988-10       Impact factor: 10.864

8.  Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.

Authors:  A Morris; G Nicholson
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

9.  Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori.

Authors:  Ryuta Takenaka; Kenji Yokota; Motowo Mizuno; Hiroyuki Okada; Tatsuya Toyokawa; Rie Yamasaki; Tadashi Yoshino; Toshiro Sugiyama; Masahiro Asaka; Yasushi Shiratori; Keiji Oguma
Journal:  Helicobacter       Date:  2004-06       Impact factor: 5.753

10.  Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis.

Authors:  Taner Bayraktaroğlu; Ahmet Sükrü Aras; Selim Aydemir; Can Davutoğlu; Yücel Ustündağ; Hulusi Atmaca; Ali Borazan
Journal:  Mediators Inflamm       Date:  2004-02       Impact factor: 4.711

View more
  8 in total

Review 1.  Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 2.  A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System.

Authors:  Hai Long; Wei Liao; Ling Wang; Qianjin Lu
Journal:  Transfus Med Hemother       Date:  2016-03-18       Impact factor: 3.747

3.  What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?

Authors:  Hidekazu Suzuki; Juntaro Matsuzaki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

4.  Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M De Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  Parkinsons Dis       Date:  2011-04-13

5.  Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M de Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  ISRN Neurol       Date:  2011-04-17

6.  Helicobacter pylori outer membrane vesicle proteins induce human eosinophil degranulation via a β2 Integrin CD11/CD18- and ICAM-1-dependent mechanism.

Authors:  Su Hyuk Ko; Jong Ik Jeon; Young-Jeon Kim; Ho Joo Yoon; Hyeyoung Kim; Nayoung Kim; Joo Sung Kim; Jung Mogg Kim
Journal:  Mediators Inflamm       Date:  2015-03-04       Impact factor: 4.711

7.  Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation.

Authors:  Isabelle C Arnold; Mariela Artola-Borán; Paulino Tallón de Lara; Andreas Kyburz; Christian Taube; Karen Ottemann; Maries van den Broek; Shida Yousefi; Hans-Uwe Simon; Anne Müller
Journal:  J Exp Med       Date:  2018-07-03       Impact factor: 14.307

8.  APRIL-producing eosinophils are involved in gastric MALT lymphomagenesis induced by Helicobacter sp infection.

Authors:  Alice Blosse; Sara Peru; Michael Levy; Benoit Marteyn; Pauline Floch; Elodie Sifré; Alban Giese; Martine Prochazkova-Carlotti; Lamia Azzi Martin; Pierre Dubus; Francis Mégraud; Agnès Ruskone Fournestraux; Bettina Fabiani; Christiane Copie Bergman; Cyrielle Robe; Michael Hahne; Bertrand Huard; Philippe Lehours
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.